Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A N=40 Randomized Single-blind Prevention

Lung and Breast Cancer Prevention by an Integrated Intervention of Maternal Smoking Cessation and Breastfeeding

Smoking, Cigarette · Breastfeeding

Bottom Line

View on ClinicalTrials.gov: NCT05123118 ↗
Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Apr 2025
Primary outcome: Primary: Number of Participants With Smoking Abstinence — 8; 3 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Integrated intervention of smoking cessation and breastfeeding (Behavioral); Attention placebo control (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
Xiaozhong Wen
Primary completion
Oct 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Smoking Abstinence		 8; 3 —
PRIMARY
Number of Participants With Reported Intent to Breastfeed		 16; 10 —
PRIMARY
Number of Participants Reporting to Breastfeed		 6; 3 —

Summary

This pilot clinical trial aims to integrate maternal smoking cessation and breastfeeding interventions to enhance both cancer prevention behaviors. The investigators will recruit 40 daily smoking women in their early pregnancy and randomize them into the integrated intervention or control group. Main outcomes include smoking abstinence and breastfeeding rates at 6 months postpartum.

Eligibility Criteria

Inclusion Criteria

  • Be 18 years or older
  • At ≤28 weeks of pregnancy
  • Daily smoking cigarettes and/or cigars in the past 7 days
  • Be able to read, listen, and talk in English

Exclusion Criteria

  • Being diagnosed with cancer
  • Current heavy drinking (more than 2 drinks a day)
  • Current use of illicit substances
  • Medical conditions contraindicating breastfeeding such as HIV infection, active tuberculosis, and breast removal
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05123118). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search